Navigation Links
Hanger Reports First Quarter 2013 Results
Date:5/1/2013

AUSTIN, Texas, May 1, 2013 /PRNewswire/ --

  • Reports $0.27 diluted EPS
  • Reports adjusted diluted EPS of $0.28, an increase of 12%
  • Realigns business segments to better reflect market strategy
  • Reaffirms full year 2013 guidance
  • Hanger, Inc. (NYSE: HGR) announced net sales of $233.5 million for the quarter ended March 31, 2013, an increase of $15.4 million, or 7.1%, from $218.1 million for the first quarter of 2012.
    Diluted earnings per share were $0.27 for the first quarter of 2013 compared to $0.25 for the same period of 2012.  Adjusted diluted earnings per share, which excludes costs related to acquisitions and the roll out of the Company's clinic management system (which the Company refers to as "Janus"), increased 12.0% to $0.28 for the first quarter of 2013 from $0.25 for the first quarter of 2012.

    In the first quarter of 2013, the Company realigned its reporting segments and management structure (the "realignment") to better reflect its dual strategy of growth within the existing O&P market and expansion into adjacent markets. The Company has divided its operations into two segments: Patient Care and Products & Services.  The Patient Care segment will now include its contracting and network management division, Linkia, which was previously reported within the "Other" segment.
    The Products & Services segment will combine the two segments previously reported as Distribution and Therapeutic Solutions.  The realignment will enable the Products & Services segment to integrate its technologies, products and services, sales force and other personnel to meet the demands of its key end-markets.  The change will also allow both segments to better focus on growth strategies and operating efficiencies that leverage their scale and market position.

    The first quarter net sales increase of $15.4
    '/>"/>

    SOURCE Hanger, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
    2. Hanger Files Form 10-K for Year Ended December 31, 2012
    3. Hanger Reports $0.62 Diluted EPS for the Fourth Quarter 2012
    4. Hanger, Inc. Has Record Year In O&P Acquisitions:
    5. Hanger Reports Earnings of $0.50 Per Diluted Share for the Third Quarter 2012
    6. Hanger, Inc. Announces 2012 Year To Date Acquisitions Totaling $35.6 Million Of Annual Net Revenue
    7. Hanger, Inc. Reports Earnings of $0.50 Per Diluted Share for the Second Quarter 2012
    8. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
    9. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
    10. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
    11. Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... 2015  CytomX Therapeutics, Inc., a biopharmaceutical company developing ... the filing of a registration statement on Form S-1 ... to a proposed initial public offering of its common ... the price range for the offering have not yet ... under the symbol "CTMX" on the NASDAQ Global Market. ...
    (Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Originally discovered ... as Yoshitomi Pharmaceutical Industries, Ltd) as an inflammatory ... by Senju Pharmaceutical Co., Ltd under the trade ...
    (Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... Capacity and Production" report to their offering. ... Survey of Biopharmaceutical Manufacturing Capacity and Production is ... contract manufacturing organizations, current and projected future capacity ...
    Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Pranoprofen Market, 2010-2019 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2
    ... N.C., June 20, 2011 Pharmaceutical Institute, the ... pharmaceutical and biotech industry and a subsidiary of ... updates to its Therapeutic Area Essentials™ ... disease state training for pharmaceutical and biotech R&D ...
    ... dreamed of becoming a pilot for as long as he can ... child opting to play with toy planes instead of cars, and ... a family trip to Disney World.  At 8-years old Baniecki scribbled ... airline pilot and placed it into a time capsule.  Ten years ...
    Cached Medicine Technology:Therapeutic Area Essentials "Class of 2011" Brings Current Disease State Training to Pharma 2Pilot's Dream Comes True Thanks to New Robotic Surgery 2Pilot's Dream Comes True Thanks to New Robotic Surgery 3Pilot's Dream Comes True Thanks to New Robotic Surgery 4
    (Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over 40 particle ... 15 seconds of unique footage that users can shrink and stretch in the Final ... more. Users can customize color, brightness, scale, speed, range, and flare attributes with intuitive ...
    (Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... the company to freely market and sell Arterosil and Arterosil HP, and that ... Sciences, LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United States ...
    (Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... No Malaria Day at the Zoo to celebrate children helping children, a thank ... their congregations throughout West Ohio have contributed to the United Methodist initiative to ...
    (Date:8/28/2015)... ... , ... For Dallas, the time is nearing for the annual Heart Walk, ... , The American Heart Association hosts their well-known Heart Walk to raise money in ... difference can be made. Walkers can participate in the cause and someone can also ...
    (Date:8/28/2015)... ... , ... On May 30th, 2015, Best Drug Rehabilitation, a results-based substance abuse ... Mission” benefit concert in Mendon, IL. Held in the Show Barn at the Adams ... education programs in the underfunded local school districts of Mendon at neighboring Quincy, IL. ...
    Breaking Medicine News(10 mins):Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
    ... with profound hearing disabilities and President A.P.J.Abdul Kalam today ... to intensify their drive to reduce the number of ... the 3rd Cochlear Implant Group of India Conference in ... with severe hearing disability, 0.9 million people with moderate ...
    ... has been found to have less side effects and ... the allergen is given as a vaccine in order ... antibodies which are already present helps to counteract the ... injections against allergy diseases such as hay fever, cat ...
    ... leader Colgate-Palmolive Company has entered into an alliance with ... designed to fight against pre-cancerous //conditions in the oral ... this end Colgate purchased $20 million of Introgen shares ... by Introgen. Introgen has a wide range of molecular ...
    ... November issue of the Journal of the National Cancer Institute, ... treatment, and patients treated with the higher chemotherapy dose had ... testicular cancer is the most common cancer among 20-40 year ... age at which they are starting a family, and the ...
    ... that rheumatoid arthritis patients respond differently to the same ... new study now explains that it is due to ... following experiments conducted on animal models of mouse that ... such complex behaviors could enable physicians make an individualized ...
    ... FDA approved long-term treatment regime for patients with treatment ... now being offered to patients at NewYork-Presbyterian Hospital/Columbia University ... first treatment specifically approved for TRD in patients over ... been unsuccessful atleast in four or more of the ...
    Cached Medicine News:Health News:Kalam Appeals to Eradicate Hearing Disability 2Health News:Oral Edible vaccine for Allergy Vaccines 2Health News:Decline in Paternity Rates Following Treatment for Testicular Cancer 2Health News:Study Offers Insights Into Treatment Of Rheumatoid Arthritis 2Health News:FDA Approved Nerve-Stimulation Therapy Now Available In New York 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: